ABCELY
LIVE

Serial Number

79396077

Owner

ABCELY

Attorney

Steven J. Solomon

Filing Date

Mar 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ABCELY Trademark

Serial Number: 79396077 • Registration: 8258087

ABCELY is a trademark filed by ABCELY on March 20, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ABCELY

2 Rue Crucy

Entity Type: 99

Trademark Details

Filing Date

March 20, 2024

Registration Date

May 19, 2026

Published for Opposition

March 31, 2026

Goods & Services

Pharmaceutical preparations for treatment of cancers, namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; sanitary preparations for medical use; chemical and biological preparations for pharmaceutical use for the treatment of cancers, namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; biological reagents for medical purposes; radioactive pharmaceutical preparations for use in in vivo diagnostics; pharmaceutical preparations for medical use, specifically for the treatment of cancers namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; biological preparations for diagnosis of cancers, namely, lung cancer, colorectal cancer, stomach cancer, esophageal cancer, cervical cancer, breast cancer, pancreatic cancer, prostate cancer; biological and pharmaceutical preparations for the prevention and treatment of cancer; human immunoglobulin being pharmaceutical preparations for the treatment of cancer, and inflammatory and infectious diseases; none of the aforementioned products relating to the veterinary field and animal health.

Biotechnology research; biological research, clinical research in the field of cancer, and inflammatory and infectious diseases; medical research; medical research laboratory services; none of the aforementioned services relating to the veterinary field and animal health.

Collection and preservation of human biological tissue, blood and cells; medical diagnostic services; medical treatment services; medical testing for diagnostic or treatment purposes; medical analysis services for the diagnosis and treatment of persons; analysis and treatment of blood plasma and stem cells being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing information and data for medical diagnosis and treatment; providing information in the field of cancer prevention, screening, diagnosis and treatment; none of the aforementioned services relating to the veterinary field and animal health

Chemicals for use in industry and science; chemicals for use in industry, specifically for biotechnological product development; chemical additives used in the manufacture of medicines or other active chemical ingredients; chemical and biological preparations for use in industry and science; none of the aforementioned products relating to the veterinary field and animal health.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 19, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 5, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 5, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 5, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 5, 2026 CNEA
ASSIGNED TO EXAMINER
Feb 26, 2026 DOCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 7, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 22, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 22, 2025 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 14, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 28, 2025 GNFN
FINAL REFUSAL E-MAILED
Jun 28, 2025 GNFR
FINAL REFUSAL WRITTEN
Jun 28, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 28, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 19, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 29, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 28, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 29, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 23, 2024 REPR